Skip to content
Medpointe

Deal Announcement: Corbett Keeling advised a co-investor to Carlyle Partners

Medpointe, the pharmaceuticals company, was bought by its management team in a buy-out led by Carlyle Partners. Corbett Keeling advised a co-investor to Carlyle Partners.

Corbett Keeling Limited is authorised and regulated by the Financial Conduct Authority (FRN 165387).

© 2025 Corbett Keeling. All rights are reserved.